Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stadler

Showing results (191-200 of 213) with videos related to

Pageof 22
Sort By:
Der Pathologe|June 14, 2012
[BRAF mutation detection in metastatic melanoma]M Dietel, A Enk, A Lehmann, et al.
Leukemia|November 23, 2007
Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3N Booken, A Gratchev, J Utikal, et al.
Developmental Cell|July 21, 2023
Localization of the Drosophila pioneer factor GAF to subnuclear foci is driven by DNA binding and required to silence satellite repeat expressionMarissa M Gaskill, Isabella V Soluri, Annemarie E Branks, et al.
Theory in Biosciences = Theorie in Den Biowissenschaften|January 19, 2008
Evolutionary patterns of non-coding RNAsAthanasius F Bompfünewerer, Christoph Flamm, Claudia Fried, et al.
Leukemia|February 19, 2014
The leukemogenicity of Hoxa9 depends on alternative splicingC R Stadler, N Vegi, M A Mulaw, et al.
Experimental Dermatology|September 2, 2024
Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patientsS Melchers, M Roemer, J D Albrecht, et al.
Yonsei Medical Journal|March 24, 1998
Epidemiological features of Adamantiades-Behçet's disease in Germany and in EuropeC C Zouboulis, I Kötter, D Djawari, et al.
Oncoimmunology|October 20, 2023
Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibodyHayat Bähr-Mahmud, Ursula Ellinghaus, Christiane R Stadler, et al.
Clinical and Experimental Rheumatology|October 28, 2006
Prevalence of Adamantiades-Behçet's disease in Germany and the municipality of Berlin: results of a nationwide surveyN G Papoutsis, M B Abdel-Naser, A Altenburg, et al.
The British Journal of Dermatology|February 3, 2016
Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/Sézary syndromeF Child, P L Ortiz-Romero, R Alvarez, et al.
Pageof 22

Showing results (191-200 of 213) with videos related to

Sort By:
Pageof 22
Der Pathologe|June 14, 2012
[BRAF mutation detection in metastatic melanoma]M Dietel, A Enk, A Lehmann, et al.
Leukemia|November 23, 2007
Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3N Booken, A Gratchev, J Utikal, et al.
Developmental Cell|July 21, 2023
Localization of the Drosophila pioneer factor GAF to subnuclear foci is driven by DNA binding and required to silence satellite repeat expressionMarissa M Gaskill, Isabella V Soluri, Annemarie E Branks, et al.
Theory in Biosciences = Theorie in Den Biowissenschaften|January 19, 2008
Evolutionary patterns of non-coding RNAsAthanasius F Bompfünewerer, Christoph Flamm, Claudia Fried, et al.
Leukemia|February 19, 2014
The leukemogenicity of Hoxa9 depends on alternative splicingC R Stadler, N Vegi, M A Mulaw, et al.
Experimental Dermatology|September 2, 2024
Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patientsS Melchers, M Roemer, J D Albrecht, et al.
Yonsei Medical Journal|March 24, 1998
Epidemiological features of Adamantiades-Behçet's disease in Germany and in EuropeC C Zouboulis, I Kötter, D Djawari, et al.
Oncoimmunology|October 20, 2023
Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibodyHayat Bähr-Mahmud, Ursula Ellinghaus, Christiane R Stadler, et al.
Clinical and Experimental Rheumatology|October 28, 2006
Prevalence of Adamantiades-Behçet's disease in Germany and the municipality of Berlin: results of a nationwide surveyN G Papoutsis, M B Abdel-Naser, A Altenburg, et al.
The British Journal of Dermatology|February 3, 2016
Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/Sézary syndromeF Child, P L Ortiz-Romero, R Alvarez, et al.
Pageof 22